These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2812067)

  • 1. An interview with FDA Commissioner Frank Young. Interview by Carmella Bocchino.
    Young FE
    Nurs Econ; 1989; 7(5):242-8. PubMed ID: 2812067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interview with FDA commissioner Hayes.
    Small WE
    Am Pharm; 1981 Oct; NS21(10):27-36. PubMed ID: 6803557
    [No Abstract]   [Full Text] [Related]  

  • 3. Janet Woodcock discusses the FDA and the drug development process. Interview by Christopher Watson.
    Woodcock J
    Drug Discov Today; 2004 Jul; 9(13):548-50. PubMed ID: 15203087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The process of drug decision making: perspectives of an FDA Commissioner.
    Hayes AH
    Hosp Formul; 1985 Aug; 20(8):896-900. PubMed ID: 10272396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interview with Janet Woodcock.
    Woodcock J
    Bioanalysis; 2010 Sep; 2(9):1535-8. PubMed ID: 21083281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA commissioner discusses issues of concern to hospital pharmacists. Interview by William A. Zellmer.
    Goyan JE
    Am J Hosp Pharm; 1980 May; 37(5):738-40 contd. PubMed ID: 7386484
    [No Abstract]   [Full Text] [Related]  

  • 7. The drug approval process and the FDA.
    Schmidt AM
    Conn Med; 1975 Apr; 39(4):237-40. PubMed ID: 1149447
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA paves the way for drug law reform.
    Eichelberger BM
    Am J Hosp Pharm; 1978 Jul; 35(7):878, 882. PubMed ID: 665706
    [No Abstract]   [Full Text] [Related]  

  • 9. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA reform in Congress: FDA's concerns. Food and Drug Administration.
    James JS
    AIDS Treat News; 1996 Apr; (no 245):5-7. PubMed ID: 11363624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kelsey's Commandos: FDA investigates the investigators.
    Small WE
    Am Pharm; 1979 Jun; 19(6):30-3. PubMed ID: 463736
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescription for change: an interview with FDA Commissioner Dr. David Kessler.
    Kessler D
    Physician Assist; 1992 Jul; 16(7):61-2, 65, 68-70. PubMed ID: 10120389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demystifying the FDA: Commissioner Young punches some holes in the "black box'. Interview by Don L. Gibbons.
    Young FE
    Med World News; 1985 May; 26(9):78-9, 83-4, 89-90 passim. PubMed ID: 10271160
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA reform in Congress: interview with Peter Barton Hutt. Food and Drug Administration. Interview by John S. James.
    Hutt PB
    AIDS Treat News; 1996 Apr; (no 245):4-5. PubMed ID: 11363623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critics fear the FDA is going too far in cutting industry's regulatory load.
    Demkovich LE
    Natl J (Wash); 1982 Jul; 14(29):1249-52. PubMed ID: 10255878
    [No Abstract]   [Full Text] [Related]  

  • 16. The drug approval process and the information it provides.
    Myers A; Moore SR
    Drug Intell Clin Pharm; 1987 Oct; 21(10):821-6. PubMed ID: 3322757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drug and antibiotic regulations--FDA. Proposed rule.
    Fed Regist; 1982 Oct; 47(202):46622-66. PubMed ID: 10262075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mission: promoting, protecting the public health. FDA Commissioner Mark B. McClellan. Interview by Ray Formanek Jr.
    McClellan MB
    FDA Consum; 2003; 37(2):12-7. PubMed ID: 12715764
    [No Abstract]   [Full Text] [Related]  

  • 19. The latest word from the FDA: an exclusive interview with the commissioner. Interview by John A. Owen Jr.
    Hayes AH
    Hosp Formul; 1982 Aug; 17(8):1063-8, 1075. PubMed ID: 10256696
    [No Abstract]   [Full Text] [Related]  

  • 20. The Food and Drug Administration's early access and fast-track approval initiatives: how have they worked?
    Shulman SR; Brown JS
    Food Drug Law J; 1995; 50(4):503-31. PubMed ID: 10343017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.